For the pathological features, in addition to the Ki-67 index, we were particularly interested in the p53 status because studies have demonstrated that p53 is frequently mutated in MCL, and is associated with treatment resistance and inferior outcomes [20–23]. This evidence concerns the gene TP53 and mantle cell lymphoma.